Xiao-bo Du

2.6k citations
107 papers · 1.9k · 2 hit papers · h-index 20

Impact in

Papers in

Xiao-bo Du

92 papers receiving 1.9k citations

Xiao-bo Du's Hit Papers

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant 2024 · 119 citations
1190+1+3Years since publication4080120

Peers

Xiao-bo Du
Comparison fields: 5 of 114
  • Drug Discovery 14
  • Radiation 238
  • Otorhinolaryngology 114
  • Biochemistry 92
  • Pulmonary and Respiratory Medicine 398
Replace Joo‐Young Kim with:
Joo‐Young Kim South Korea
Giusi Irma Forte Italy
John Kouvaris Greece
Mahshid Ghoncheh Iran
Ron Epelbaum Israel
Stuart O. Zimmerman United States
Shaoming Wang China
Steven E. Waggoner United States
Kazuto Ito Japan
Cláudia Marchetti Italy
Xiao-bo Du relative to Joo‐Young Kim South Korea Joo‐Young Kim's profile →
Citations per field
00.5×2×3×3.5×
Joo‐Young Kim · 1×
Citations per year

Countries citing papers authored by Xiao-bo Du

Since Specialization
Citations

This map shows the geographic impact of Xiao-bo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-bo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-bo Du more than expected).

Fields of papers citing papers by Xiao-bo Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-bo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-bo Du. The network helps show where Xiao-bo Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiao-bo Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiao-bo Du Line = papers co-authored together Xiao-bo Du links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006227
2 2011146
3
FLASH Radiotherapy: History and Future
Hit paper breakdown →
2021140
4 2021119
5
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
Hit paper breakdown →
2024119
6 2007108
7 2017103
8 201783
9 202247
10 202143
11 202031
12 200930
13 202230
14 202326
15 199825
16 200824
17 201122
18 201722
19 201221
20 201921

About Xiao-bo Du

Xiao-bo Du is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Oncology, having authored 107 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (15 papers), Esophageal Cancer Research and Treatment (11 papers), Radiation Therapy and Dosimetry (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Effects of Radiation Exposure (5 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Women's cancer prevention and management (4 papers). The work is most often cited by research in Drug Discovery (14 citations), Radiation (238 citations), Otorhinolaryngology (114 citations), Biochemistry (92 citations) and Pulmonary and Respiratory Medicine (398 citations). Xiao-bo Du has collaborated with scholars based in China and United States. Frequent co-authors include Binwei Lin, Tangzhi Dai, Gang Ling Feng, Feng Gao, Dai Wu, Yiwei Yang, Wen‐xiu Yao, Ke Xie, Wenxiu Yao and Guangli Yang. Their work appears in journals such as Frontiers in Oncology, Medicine, Radiation Oncology, PLoS ONE and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact